Next Article in Journal
Innovative Payment Mechanisms for High-Cost Medical Devices in Latin America: Experience in Designing Outcome Protection Programs in the Region
Next Article in Special Issue
European Health Technology Assessment Considerations Related to Gene Therapies in Eyecare: The Neovascular Age-Related Macular Degeneration Example
Previous Article in Journal
Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past?
Previous Article in Special Issue
Preparing for the EU HTA Regulation: Insights from the Dutch Perspective
 
 
Review

Article Versions Notes

J. Mark. Access Health Policy 2025, 13(3), 38; https://doi.org/10.3390/jmahp13030038
Action Date Notes Link
article xml file uploaded 28 July 2025 09:01 CEST Original file -
article xml uploaded. 28 July 2025 09:01 CEST Update https://www.mdpi.com/2001-6689/13/3/38/xml
article pdf uploaded. 28 July 2025 09:01 CEST Version of Record https://www.mdpi.com/2001-6689/13/3/38/pdf
article html file updated 28 July 2025 09:03 CEST Original file https://www.mdpi.com/2001-6689/13/3/38/html
Back to TopTop